Literature DB >> 33762691

The oncology market for antibody-drug conjugates.

Carolina do Pazo, Khurram Nawaz, Rachel M Webster.   

Abstract

Year:  2021        PMID： 33762691     DOI： 10.1038/d41573-021-00054-2

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  14 in total

1.  Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin.

Authors:  Ping Chen; Brandon M Bordeau; Yu Zhang; Joseph P Balthasar
Journal:  Mol Cancer Ther       Date:  2022-10-07       Impact factor: 6.009

Review 2.  Chemical Conjugation in Drug Delivery Systems.

Authors:  Alexis Eras; Danna Castillo; Margarita Suárez; Nelson Santiago Vispo; Fernando Albericio; Hortensia Rodriguez
Journal:  Front Chem       Date:  2022-05-26       Impact factor: 5.545

3.  Evaluation of Cellular Targeting by Fab' vs Full-Length Antibodies in Antibody-Nanoparticle Conjugates (ANCs) Using CD4 T-cells.

Authors:  Khushboo Singh; Mine Canakci; Pintu Kanjilal; Natalie Williams; Sudarvili Shanthalingam; Barbara A Osborne; S Thayumanavan
Journal:  Bioconjug Chem       Date:  2022-02-09       Impact factor: 6.069

4.  Synthesis and Evaluation of Three Azide-Modified Disaccharide Oxazolines as Enzyme Substrates for Single-Step Fc Glycan-Mediated Antibody-Drug Conjugation.

Authors:  Xiao Zhang; Chong Ou; Huiying Liu; Lai-Xi Wang
Journal:  Bioconjug Chem       Date:  2022-05-11       Impact factor: 6.069

5.  Site-Specific Chemoenzymatic Conjugation of High-Affinity M6P Glycan Ligands to Antibodies for Targeted Protein Degradation.

Authors:  Xiao Zhang; Huiying Liu; Jia He; Chong Ou; Thomas C Donahue; Musleh M Muthana; Lishan Su; Lai-Xi Wang
Journal:  ACS Chem Biol       Date:  2022-03-22       Impact factor: 4.634

6.  General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates.

Authors:  Xiao Zhang; Chong Ou; Huiying Liu; Sunaina Kiran Prabhu; Chao Li; Qiang Yang; Lai-Xi Wang
Journal:  ACS Chem Biol       Date:  2021-09-27       Impact factor: 5.100

Review 7.  Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.

Authors:  Aiping Zhang; Kai Miao; Heng Sun; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2022-04-24       Impact factor: 10.750

8.  Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections.

Authors:  Arianne Lovey; Mila Krel; Allen Borchardt; Thomas Brady; Jason N Cole; Quyen-Quyen Do; Joanne Fortier; Grayson Hough; Wanlong Jiang; Alain Noncovich; Les Tari; Qiping Zhao; James M Balkovec; Yanan Zhao; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

9.  First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors.

Authors:  Chiara Testa; Anna Maria Papini; Reinhard Zeidler; Daniela Vullo; Fabrizio Carta; Claudiu T Supuran; Paolo Rovero
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

10.  One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling.

Authors:  Chong Ou; Chao Li; Roushu Zhang; Qiang Yang; Guanghui Zong; Yuanwei Dai; Rebecca L Francis; Stylianos Bournazos; Jeffrey V Ravetch; Lai-Xi Wang
Journal:  Bioconjug Chem       Date:  2021-08-05       Impact factor: 6.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.